These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 23992266

  • 1. Increased circulating soluble vascular adhesion protein-1 levels in systemic sclerosis: association with lower frequency and severity of interstitial lung disease.
    Yanaba K, Yoshizaki A, Muroi E, Ogawa F, Shimizu K, Sato S.
    Int J Rheum Dis; 2013 Aug; 16(4):442-7. PubMed ID: 23992266
    [Abstract] [Full Text] [Related]

  • 2. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
    Kurkijärvi R, Adams DH, Leino R, Möttönen T, Jalkanen S, Salmi M.
    J Immunol; 1998 Aug 01; 161(3):1549-57. PubMed ID: 9686623
    [Abstract] [Full Text] [Related]

  • 3. Serum CCL23 levels are increased in patients with systemic sclerosis.
    Yanaba K, Yoshizaki A, Muroi E, Ogawa F, Asano Y, Kadono T, Sato S.
    Arch Dermatol Res; 2011 Jan 01; 303(1):29-34. PubMed ID: 20824279
    [Abstract] [Full Text] [Related]

  • 4. Clinical significance of soluble CD31 in patients with systemic sclerosis (SSc): association with limited cutaneous SSc.
    Sato S, Komura K, Hasegawa M, Fujimoto M, Takehara K.
    J Rheumatol; 2001 Nov 01; 28(11):2460-5. PubMed ID: 11708419
    [Abstract] [Full Text] [Related]

  • 5. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
    Yoshikawa N, Noda K, Shinoda H, Uchida A, Ozawa Y, Tsubota K, Mashima Y, Ishida S.
    J Diabetes Complications; 2013 Nov 01; 27(2):162-6. PubMed ID: 23062326
    [Abstract] [Full Text] [Related]

  • 6. Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
    Massabki PS, Silva NP, Lourenço DM, Andrade LE.
    J Rheumatol; 2003 Dec 01; 30(12):2606-12. PubMed ID: 14719201
    [Abstract] [Full Text] [Related]

  • 7. Soluble vascular adhesion protein-1: decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury.
    Lin Z, Han M, Li H, Luo H, Zhang Y, Luo W.
    Clin Chim Acta; 2011 Aug 17; 412(17-18):1678-82. PubMed ID: 21645499
    [Abstract] [Full Text] [Related]

  • 8. Elevated circulating CD40L concentrations in patients with systemic sclerosis.
    Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K.
    J Rheumatol; 2004 Mar 17; 31(3):514-9. PubMed ID: 14994397
    [Abstract] [Full Text] [Related]

  • 9. Serum levels of soluble vascular endothelial growth factor receptor-2 in patients with systemic sclerosis.
    Jinnin M, Makino T, Kajihara I, Honda N, Makino K, Ogata A, Ihn H.
    Br J Dermatol; 2010 Apr 17; 162(4):751-8. PubMed ID: 19886888
    [Abstract] [Full Text] [Related]

  • 10. Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis.
    Yanaba K, Muroi E, Yoshizaki A, Hara T, Ogawa F, Shimizu K, Yozaki M, Hasegawa M, Fujimoto M, Takehara K, Sato S.
    J Rheumatol; 2009 Sep 17; 36(9):1917-23. PubMed ID: 19605674
    [Abstract] [Full Text] [Related]

  • 11. Serum interleukin 9 levels are increased in patients with systemic sclerosis: association with lower frequency and severity of pulmonary fibrosis.
    Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S.
    J Rheumatol; 2011 Oct 17; 38(10):2193-7. PubMed ID: 21807780
    [Abstract] [Full Text] [Related]

  • 12. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
    Toiyama Y, Miki C, Inoue Y, Kawamoto A, Kusunoki M.
    J Surg Oncol; 2009 May 01; 99(6):368-72. PubMed ID: 19204971
    [Abstract] [Full Text] [Related]

  • 13. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
    Yasuda H, Toiyama Y, Ohi M, Mohri Y, Miki C, Kusunoki M.
    J Surg Oncol; 2011 Jun 01; 103(7):695-9. PubMed ID: 21308684
    [Abstract] [Full Text] [Related]

  • 14. Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosis.
    Yanaba K, Asano Y, Noda S, Akamata K, Aozasa N, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sumida H, Kuwano Y, Tada Y, Sugaya M, Kadono T, Sato S.
    Br J Dermatol; 2012 Sep 01; 167(3):542-7. PubMed ID: 22540233
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis.
    Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z, Aihara M, Takahashi K.
    Br J Dermatol; 2013 Apr 01; 168(4):717-25. PubMed ID: 23110679
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.